PMH34 COST-EFFECTIVENESS OF OLANZAPINE VERSUS LITHIUM FOR THE PREVENTION OF RELAPSE IN BIPOLAR I DISORDER IN AUSTRALIA
May 1, 2004, 00:00
10.1016/S1098-3015(10)62230-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)62230-9/fulltext
Title :
PMH34 COST-EFFECTIVENESS OF OLANZAPINE VERSUS LITHIUM FOR THE PREVENTION OF RELAPSE IN BIPOLAR I DISORDER IN AUSTRALIA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)62230-9&doi=10.1016/S1098-3015(10)62230-9
First page :
Section Title :
Open access? :
No
Section Order :
166